Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study.

Williamson, S K; Lew, D; Miller, G J; Balcerzak, S P; Baker, L H; Crawford, E D

Williamson, S K; Lew, D; Miller, G J; Balcerzak, S P; Baker, L H; Crawford, E D.

Affiliation

Williamson SK; Division of Clinical Oncology, University of Kansas Medical Center, Kansas City, KS, USA.

Cancer ; 88(5): 1159-65, 2000 Mar 01.

Article in En | MEDLINE | ID: mdl-10699907

Subject(s)

Adrenal Cortex Neoplasms/drug therapy; Adrenocortical Carcinoma/drug therapy; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Adolescent; Adrenal Cortex Neoplasms/pathology; Adrenocortical Carcinoma/pathology; Adrenocortical Carcinoma/secondary; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Child; Cisplatin/administration & dosage; Cisplatin/adverse effects; Etoposide/administration & dosage; Etoposide/adverse effects; Female; Humans; Male; Middle Aged; Mitotane/administration & dosage; Mitotane/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Adrenal Cortex Neoplasms / Adrenocortical Carcinoma Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2000 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links